TIDMAPAX
RNS Number : 5914U
Apax Global Alpha Limited
06 December 2021
Apax Global Alpha Limited
Funds advised by Apax sell stakes in Unilabs
The Apax IX Fund ("Apax IX) and Apax Europe VI Fund ("Apax
Europe VI"), both of which AGA is a limited partner in, announced
that they have agreed to sell their stakes in Unilabs ("the
Company"), a leading pan-European provider of laboratory and
imaging diagnostics services, to A.P. Møller Holding. The
transaction is expected to close in Q1 2022 subject to customary
closing conditions and regulatory approvals.
The Apax IX investment in Unilabs is expected to deliver a total
gross MOIC of 3.3x and a gross IRR of 27%.(1) The Apax Europe VI
investment is expected to deliver a total gross MOIC of 5.5x and a
gross IRR of 15%. The transaction values AGA's total look through
investment in Unilabs at approximately EUR72.4m(3) . This would
represent an uplift of c.13% to Unilabs' last Unaffected
Valuation(2) and an uplift of c.EUR8.5m (c.EUR0.02 per share) in
the Adjusted Net Asset Value ("Adjusted NAV") of AGA at 30
September 2021.
Note that these figures relate to AGA's look through position of
Apax IX and Apax Europe VI's overall investments in Unilabs and are
stated before taking into account any closing adjustments, fees,
costs, and carried interest, and translated based on today's
exchange rates where applicable(3) . The sale remains subject to
customary closing conditions.
Apax Europe VI first invested in a minority stake in Unilabs in
2007, taking the Company private from the Swiss Stock Exchange and
subsequently merging it with Capio Diagnostics, a Nordic laboratory
and imaging business. In 2017, Apax IX gained majority control of
the Company by acquiring the outstanding shareholding in Unilabs
held by unaffiliated shareholders. Apax Europe VI retained its
minority stake. Since then, the Apax Funds have supported Unilabs'
significant investments into people, technology, and M&A.
Over the past years Apax has supported Unilabs in its
transformation, helping it to become a pan-European leader in
diagnostic services and a pioneer in digital radiology and
pathology. During the Apax Funds' ownership, Unilabs drew on Apax's
healthcare expertise and network as well as the support of the
Operational Excellence Practice to transform its operations and
invest in the Company's future. As a result, Unilabs grew both
organically and through M&A, completing 50+ acquisitions since
2017, and it currently operates in 15 countries with market-leading
positions in many of these.
AGA, whose shares are listed on the London Stock Exchange,
provides investors with access to the investment expertise of Apax
through its investments in a diversified portfolio of private
equity funds advised by Apax as well as derived investments in debt
and equity. AGA is an investor in Apax Europe VI with a total
commitment of EUR10.6m. In May 2016, AGA made a commitment of
c.EUR303m(4) to Apax IX.
For more information about the transaction, please visit:
https://www.apax.com/news/press-releases/
Contact details
Investor Relations - AGA
Katarina Sallerfors
T: +44 207 872 6526
E: Katarina.sallerfors@apax.com
Footnotes
1. Represents Gross IRR and Gross MOIC shown for Apax IX USD
tranche
2. Unaffected Valuation is determined as the fair value in
the last quarter before exit, when valuation is not affected
by the exit process (i.e. because an exit was signed, or
an exit was sufficiently close to being signed that the
Apax Funds incorporated the expected exit multiple into
the quarter end valuation)
3. Based on Bloomberg closing EUR/USD FX rate on 2 December
2021of 1.1338
4. Represents AGA's commitment of EUR154.5m in Apax IX euro
tranche and $175.0m in Apax IX USD tranche translated to
euro using latest closing FX rate noted above
Notes
1. Note that references in this announcement to Apax Global Alpha
Limited have been abbreviated to "AGA" or "the Company". References
to Apax Partners LLP have been abbreviated to "Apax" or "the
Investment Adviser"
2. Please be advised that this announcement may contain inside
information as stipulated under the Market Abuse Regulations
(EU) NO. 596/2014 ("MAR")
3. This announcement is not for release, publication or distribution,
directly or indirectly, in whole or in part, into or within
the United States or to "US persons" (as defined in Regulation
S under the United States Securities Act of 1933, as amended
(the "Securities Act")) or into or within Australia, Canada,
South Africa or Japan. Recipients of this announcement in jurisdictions
outside the UK should inform themselves about and observe any
applicable legal requirements in their jurisdictions. In particular,
the distribution of the announcement may be restricted by law
in certain jurisdictions
4. The information presented herein is not an offer for sale within
the United States of any equity shares or other securities
of Apax Global Alpha Limited ("AGA"). AGA has not been and
will not be registered under the US Investment Company Act
of 1940, as amended (the "Investment Company Act"). In addition,
AGA's shares (the "Shares") have not been and will not be registered
under the Securities Act or any other applicable law of the
United States. Consequently, the Shares may not be offered
or sold or otherwise transferred within the United States,
or to, or for the account or benefit of, US Persons, except
pursuant to an exemption from the registration requirements
of the Securities Act and under circumstances which will not
require AGA to register under the Investment Company Act. No
public offering of the Shares is being made in the United States
5. This announcement may include forward-looking statements. The
words "expect", "anticipate", "intends", "plan", "estimate",
"aim", "forecast", "project" and similar expressions (or their
negative) identify certain of these forward-looking statements.
These forward-looking statements are statements regarding AGA's
intentions, beliefs or current expectations concerning, among
other things, AGA's results of operations, financial condition,
liquidity, prospects, growth and strategies. The forward-looking
statements in this presentation are based on numerous assumptions
regarding AGA's present and future business strategies and
the environment in which AGA will operate in the future. Forward-looking
statements involve inherent known and unknown risks, uncertainties
and contingencies because they relate to events and depend
on circumstances that may or may not occur in the future and
may cause the actual results, performance or achievements of
AGA to be materially different from those expressed or implied
by such forward looking statements. Many of these risks and
uncertainties relate to factors that are beyond AGA's ability
to control or estimate precisely, such as future market conditions,
currency fluctuations, the behaviour of other market participants,
the actions of regulators and other factors such as AGA's ability
to continue to obtain financing to meet its liquidity needs,
changes in the political, social and regulatory framework in
which AGA operates or in economic or technological trends or
conditions. Past performance should not be taken as an indication
or guarantee of future results, and no representation or warranty,
express or implied, is made regarding future performance. AGA
expressly disclaims any obligation or undertaking to release
any updates or revisions to these forward-looking statements
to reflect any change in AGA's expectations with regard thereto
or any change in events, conditions or circumstances on which
any statement is based after the date of this announcement,
or to update or to keep current any other information contained
in this announcement. Accordingly, undue reliance should not
be placed on the forward-looking statements, which speak only
as of the date of this announcement.
About Apax Global Alpha Limited
AGA is a Guernsey registered closed-ended collective investment
scheme incorporated as a non-cellular company that listed on the
London Stock Exchange on 15 June 2015. It is regulated by the
Guernsey Financial Services Commission.
AGA's objective is to provide shareholders with capital
appreciation from its investment portfolio and regular dividends.
The Company is targeting an annualised Total Return, across
economic cycles, of 12-15% (net of fees and expenses) including a
dividend yield of 5% of Net Asset Value.
The investment policy of the Company is to make Private Equity
investments in Apax Funds, and Derived Investments which are
investments in equities and debt derived from the insights gained
via Apax Partners' Private Equity activities.
Further information regarding the Company and its publications
are available on the Company's website at
www.apaxglobalalpha.com.
About Apax
Apax Partners LLP ("Apax") is a leading global private equity
advisory firm. For nearly 50 years, Apax has worked to inspire
growth and ideas that transform businesses. The firm has raised and
advised funds with aggregate commitments of more than $60 billion.
The Apax Funds invest in companies across four global sectors of
Tech, Services, Healthcare and Internet/Consumer. These funds
provide long-term equity financing to build and strengthen
world-class companies. For further information about Apax, please
visit www.apax.com .
Apax is authorised and regulated by the Financial Conduct
Authority in the UK.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFFFSLFTLVIIL
(END) Dow Jones Newswires
December 06, 2021 02:00 ET (07:00 GMT)
Apax Global Alpha (LSE:APAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Apax Global Alpha (LSE:APAX)
Historical Stock Chart
From Apr 2023 to Apr 2024